Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance

Clinical Characteristics of Coronavirus Disease 2019 in China

(2020) Wei-jie Guan et al.   NEW ENGLAND JOURNAL OF MEDICINE

COVID-19 Associated Pulmonary Aspergillosis

(2020) Andreas L.E. van Arkel et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Bronchoscopy in COVID-19 Patients with Invasive Mechanical Ventilation: A Center Experience

(2020) Alfons Torrego et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19

(2020) Huilan Zhang et al.   ANNALS OF INTERNAL MEDICINE

The Use of Bronchoscopy During the COVID-19 Pandemic

(2020) Momen M. Wahidi et al.   CHEST

Prospective evaluation of the turbidimetric β-D-glucan assay and two lateral flow assays on serum in invasive aspergillosis

(2020) Toine Mercier et al.   CLINICAL INFECTIOUS DISEASES

Predicting infectious SARS-CoV-2 from diagnostic samples

(2020) Jared Bullard et al.   CLINICAL INFECTIOUS DISEASES

Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China

(2020) Chuan Qin et al.   CLINICAL INFECTIOUS DISEASES

COVID‐19 associated pulmonary aspergillosis

(2020) Philipp Koehler et al.   MYCOSES

Virological assessment of hospitalized patients with COVID-2019

(2020) Roman Wölfel et al.   NATURE

Multiorgan and Renal Tropism of SARS-CoV-2

(2020) Victor G. Puelles et al.   NEW ENGLAND JOURNAL OF MEDICINE

Invasive pulmonary aspergillosis complicating SARS-CoV-2 pneumonia: A diagnostic challenge

(2020) Spinello Antinori et al.   Travel Medicine and Infectious Disease

COVID-19-associated invasive pulmonary aspergillosis

(2020) Lynn Rutsaert et al.   Annals of Intensive Care

Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19

(2020) Alexandre Alanio et al.   Lancet Respiratory Medicine

Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options

(2020) Erin K McCreary et al.   Open Forum Infectious Diseases

Detection of Invasive Pulmonary Aspergillosis in COVID-19 with Non-directed Bronchoalveolar Lavage

(2020) Stefaan Van Biesen et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Tocilizumab for treatment of mechanically ventilated patients with COVID-19

(2020) Emily C Somers et al.   CLINICAL INFECTIOUS DISEASES

Epidemiology of invasive pulmonary aspergillosis among COVID-19 intubated patients: a prospective study

(2020) Michele Bartoletti et al.   CLINICAL INFECTIOUS DISEASES

Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards

(2020) Bernard La Scola et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion

(2020) Paul E. Verweij et al.   INTENSIVE CARE MEDICINE

Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers

(2020) Catherine F Houlihan et al.   LANCET

COVID‐19‐associated pulmonary aspergillosis (CAPA) in patients admitted with severe COVID‐19 pneumonia: An observational study from Pakistan

(2020) Nosheen Nasir et al.   MYCOSES

Is the COVID-19 Pandemic a Good Time to Include Aspergillus Molecular Detection to Categorize Aspergillosis in ICU Patients? A Monocentric Experience

(2020) Jean-Pierre Gangneux et al.   Journal of Fungi

Isavuconazole Treatment in a Mixed Patient Cohort with Invasive Fungal Infections: Outcome, Tolerability and Clinical Implications of Isavuconazole Plasma Concentrations

(2020) Christoph Zurl et al.   Journal of Fungi

COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment

(2020) Amir Arastehfar et al.   Journal of Fungi

Azole-Resistant COVID-19-Associated Pulmonary Aspergillosis in an Immunocompetent Host: A Case Report

(2020) Eelco F. J. Meijer et al.   Journal of Fungi

Performance of the Bronchoalveolar Lavage Fluid Aspergillus Galactomannan Lateral Flow Assay With Cube Reader for Diagnosis of Invasive Pulmonary Aspergillosis: A Multicenter Cohort Study

(2020) Jeffrey D Jenks et al.   CLINICAL INFECTIOUS DISEASES

APX001 Pharmacokinetic/Pharmacodynamic Target Determination against Aspergillus fumigatus in an In Vivo Model of Invasive Pulmonary Aspergillosis

(2019) Miao Zhao et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Intensive Care management of influenza-associated pulmonary aspergillosis

(2019) Philipp Koehler et al.   CLINICAL MICROBIOLOGY AND INFECTION

Baseline predictors influencing the prognosis of invasive aspergillosis in adults

(2019) Philipp Koehler et al.   MYCOSES

Development and internal validation of a model for predicting 60-day risk of invasive mould disease in patients with haematological malignancies

(2019) Marta Stanzani et al.   JOURNAL OF INFECTION

Lateral flow assays for diagnosing invasive pulmonary aspergillosis in adult hematology patients: A comparative multicenter study

(2019) Toine Mercier et al.   MEDICAL MYCOLOGY

Ibrexafungerp: A novel oral glucan synthase inhibitor

(2019) M R Davis et al.   MEDICAL MYCOLOGY

Respiratory specimens and the diagnostic accuracy of Aspergillus lateral flow assays (LFA-IMMY™): real-life data from a multicentre study

(2019) C. Lass-Flörl et al.   CLINICAL MICROBIOLOGY AND INFECTION

New drugs target growing threat of fatal fungi

(2019) Kai Kupferschmidt   SCIENCE

Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium

(2019) J Peter Donnelly et al.   CLINICAL INFECTIOUS DISEASES

High‐dose posaconazole for azole‐resistant aspergillosis and other difficult‐to‐treat mould infections

(2019) Alexander F. A. D. Schauwvlieghe et al.   MYCOSES

The effect of the novel antifungal drug F901318 (Olorofim) on the growth and viability of Aspergillus fumigatus

(2018) Saskia du Pré et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

(2018) A.J. Ullmann et al.   CLINICAL MICROBIOLOGY AND INFECTION

OUP accepted manuscript

(2018)   MEDICAL MYCOLOGY

Isavuconazole shortens the QTc interval

(2018) Sibylle C. Mellinghoff et al.   MYCOSES

Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy

(2018) Jeffrey D Jenks et al.   Drug Design Development and Therapy

Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study

(2018) Alexander F A D Schauwvlieghe et al.   Lancet Respiratory Medicine

Triazole resistance in Aspergillus fumigatus: recent insights and challenges for patient management

(2018) Pieter P.A. Lestrade et al.   CLINICAL MICROBIOLOGY AND INFECTION

Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease

(2017) Oliver A Cornely et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

A prospective study of fungal biomarkers to improve management of invasive fungal diseases in a mixed specialty critical care unit

(2017) Alida Fe Talento et al.   JOURNAL OF CRITICAL CARE

Real-world challenges and unmet needs in the diagnosis and treatment of suspected invasive pulmonary aspergillosis in patients with haematological diseases: An illustrative case study

(2017) Martin Hoenigl et al.   MYCOSES

Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America

(2016) Thomas F. Patterson et al.   CLINICAL INFECTIOUS DISEASES

Influenza virus damages the alveolar barrier by disrupting epithelial cell tight junctions

(2016) Kirsty R. Short et al.   EUROPEAN RESPIRATORY JOURNAL

Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial

(2016) Johan A Maertens et al.   LANCET

Clinical evidence for caspofungin monotherapy in the first-line and salvage therapy of invasiveAspergillusinfections

(2016) Werner J. Heinz et al.   MYCOSES

Combination Antifungal Therapy for Invasive Aspergillosis

(2015) Kieren A. Marr et al.   ANNALS OF INTERNAL MEDICINE

AspergillusPolymerase Chain Reaction: Systematic Review of Evidence for Clinical Use in Comparison With Antigen Testing

(2015) P. Lewis White et al.   CLINICAL INFECTIOUS DISEASES

Influenza virus-induced lung injury: pathogenesis and implications for treatment

(2015) Susanne Herold et al.   EUROPEAN RESPIRATORY JOURNAL

Impact of special patient populations on the pharmacokinetics of echinocandins

(2015) Eline W Muilwijk et al.   Expert Review of Anti-Infective Therapy

Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease

(2015) Oliver A. Cornely et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Diagnostic accuracy of a novel lateral-flow device in invasive aspergillosis: a meta-analysis

(2015) Zhijie Pan et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Important drug classes associated with potential drug–drug interactions in critically ill patients: highlights for cardiothoracic intensivists

(2015) Shadi Baniasadi et al.   Annals of Intensive Care

Potential Factors for Inadequate Voriconazole Plasma Concentrations in Intensive Care Unit Patients and Patients with Hematological Malignancies

(2013) Martin Hoenigl et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

A Clinical Algorithm to Diagnose Invasive Pulmonary Aspergillosis in Critically Ill Patients

(2012) Stijn I. Blot et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Pandemic 2009 influenza A(H1N1) virus infection coinciding with invasive pulmonary aspergillosis in neutropenic patients

(2011) J. J. VEHRESCHILD et al.   EPIDEMIOLOGY AND INFECTION

Efficacy of caspofungin as salvage therapy for invasive aspergillosis compared to standard therapy in a historical cohort

(2010) J. W. Hiemenz et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Development of an Immunochromatographic Lateral-Flow Device for Rapid Serodiagnosis of Invasive Aspergillosis

(2008) C. R. Thornton   Clinical and Vaccine Immunology

Invasive aspergillosis in glucocorticoid-treated patients

(2008) Russell E. Lewis et al.   MEDICAL MYCOLOGY

Galactomannan in Bronchoalveolar Lavage Fluid

(2007) Wouter Meersseman et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE